Annual CFI
-$2.27 B
+$201.00 M+8.15%
31 December 2023
Summary:
Gilead Sciences annual cash flow from investing activities is currently -$2.27 billion, with the most recent change of +$201.00 million (+8.15%) on 31 December 2023. During the last 3 years, it has risen by +$866.00 million (+27.66%). GILD annual CFI is now -115.78% below its all-time high of $14.36 billion, reached on 31 December 2018.GILD Cash From Investing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CFI
-$710.00 M
-$403.00 M-131.27%
30 September 2024
Summary:
Gilead Sciences quarterly cash flow from investing activities is currently -$710.00 million, with the most recent change of -$403.00 million (-131.27%) on 30 September 2024. Over the past year, it has increased by +$17.00 million (+2.34%). GILD quarterly CFI is now -113.55% below its all-time high of $5.24 billion, reached on 30 June 2018.GILD Quarterly CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CFI
-$3.95 B
-$481.00 M-13.86%
30 September 2024
Summary:
Gilead Sciences TTM cash flow from investing activities is currently -$3.95 billion, with the most recent change of -$481.00 million (-13.86%) on 30 September 2024. Over the past year, it has dropped by -$1.69 billion (-74.44%). GILD TTM CFI is now -127.52% below its all-time high of $14.36 billion, reached on 31 December 2018.GILD TTM CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
GILD Cash From Investing Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | - | +2.3% | -74.4% |
| 3 y3 years | +27.7% | -155.4% | -26.2% |
| 5 y5 years | +71.0% | -264.7% | +49.5% |
GILD Cash From Investing High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at high | +27.7% | -210.0% | +67.8% | -109.0% | at low |
| 5 y | 5 years | at high | +84.5% | -264.7% | +92.1% | -109.0% | +75.8% |
| alltime | all time | -115.8% | +85.9% | -113.5% | +93.4% | -127.5% | +75.8% |
Gilead Sciences Cash From Investing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$710.00 M(+131.3%) | -$3.95 B(+13.9%) |
| June 2024 | - | -$307.00 M(-86.1%) | -$3.47 B(-4.8%) |
| Mar 2024 | - | -$2.21 B(+203.6%) | -$3.65 B(+61.0%) |
| Dec 2023 | -$2.27 B(-8.2%) | -$727.00 M(+217.5%) | -$2.27 B(+18.4%) |
| Sept 2023 | - | -$229.00 M(-52.6%) | -$1.91 B(-20.2%) |
| June 2023 | - | -$483.00 M(-41.5%) | -$2.40 B(+7.9%) |
| Mar 2023 | - | -$826.00 M(+120.3%) | -$2.22 B(-9.9%) |
| Dec 2022 | -$2.47 B(-21.2%) | -$375.00 M(-47.4%) | -$2.47 B(+4.1%) |
| Sept 2022 | - | -$713.00 M(+131.5%) | -$2.37 B(+25.3%) |
| June 2022 | - | -$308.00 M(-71.2%) | -$1.89 B(-12.5%) |
| Mar 2022 | - | -$1.07 B(+284.9%) | -$2.16 B(-31.0%) |
| Dec 2021 | -$3.13 B(-78.6%) | -$278.00 M(+18.8%) | -$3.13 B(-73.5%) |
| Sept 2021 | - | -$234.00 M(-59.4%) | -$11.83 B(-0.3%) |
| June 2021 | - | -$577.00 M(-71.7%) | -$11.87 B(-27.3%) |
| Mar 2021 | - | -$2.04 B(-77.3%) | -$16.31 B(+11.6%) |
| Dec 2020 | -$14.62 B(+87.0%) | -$8.98 B(+3212.5%) | -$14.62 B(+180.7%) |
| Sept 2020 | - | -$271.00 M(-94.6%) | -$5.21 B(-23.2%) |
| June 2020 | - | -$5.02 B(+1360.2%) | -$6.78 B(-14.4%) |
| Mar 2020 | - | -$344.00 M(-179.8%) | -$7.92 B(+1.3%) |
| Dec 2019 | -$7.82 B(-154.5%) | $431.00 M(-123.4%) | -$7.82 B(+41.8%) |
| Sept 2019 | - | -$1.84 B(-70.1%) | -$5.51 B(+234.7%) |
| June 2019 | - | -$6.16 B(+2425.8%) | -$1.65 B(-116.9%) |
| Mar 2019 | - | -$244.00 M(-108.9%) | $9.76 B(-32.0%) |
| Dec 2018 | $14.36 B(-189.3%) | $2.73 B(+35.1%) | $14.36 B(+795.0%) |
| Sept 2018 | - | $2.02 B(-61.4%) | $1.60 B(-163.3%) |
| June 2018 | - | $5.24 B(+20.4%) | -$2.54 B(-78.9%) |
| Mar 2018 | - | $4.35 B(-143.5%) | -$12.02 B(-25.2%) |
| Dec 2017 | -$16.07 B(+34.1%) | -$10.02 B(+373.8%) | -$16.07 B(+84.1%) |
| Sept 2017 | - | -$2.11 B(-50.2%) | -$8.73 B(-17.1%) |
| June 2017 | - | -$4.25 B(-1483.1%) | -$10.53 B(+10.1%) |
| Mar 2017 | - | $307.00 M(-111.5%) | -$9.57 B(-20.2%) |
| Dec 2016 | -$11.98 B(-3.9%) | -$2.67 B(-31.7%) | -$11.98 B(+2.0%) |
| Sept 2016 | - | -$3.92 B(+19.3%) | -$11.75 B(-2.2%) |
| June 2016 | - | -$3.28 B(+55.7%) | -$12.02 B(-2.2%) |
| Mar 2016 | - | -$2.11 B(-13.5%) | -$12.29 B(-1.5%) |
| Dec 2015 | -$12.47 B(+584.3%) | -$2.44 B(-41.8%) | -$12.47 B(+19.5%) |
| Sept 2015 | - | -$4.19 B(+17.8%) | -$10.44 B(+48.6%) |
| June 2015 | - | -$3.55 B(+54.5%) | -$7.03 B(+77.4%) |
| Mar 2015 | - | -$2.30 B(+467.7%) | -$3.96 B(+117.3%) |
| Dec 2014 | -$1.82 B(+617.7%) | -$405.00 M(-47.4%) | -$1.82 B(+51.8%) |
| Sept 2014 | - | -$770.00 M(+58.1%) | -$1.20 B(+173.5%) |
| June 2014 | - | -$487.00 M(+202.5%) | -$439.27 M(+5572.4%) |
| Mar 2014 | - | -$161.00 M(-174.3%) | -$7.74 M(-97.0%) |
| Dec 2013 | -$254.00 M(-97.9%) | $216.76 M(-2798.8%) | -$254.00 M(-39.6%) |
| Sept 2013 | - | -$8.03 M(-85.5%) | -$420.64 M(-54.8%) |
| June 2013 | - | -$55.48 M(-86.4%) | -$930.65 M(-38.4%) |
| Mar 2013 | - | -$407.26 M(-912.5%) | -$1.51 B(-87.3%) |
| Dec 2012 | -$11.85 B(-430.0%) | $50.12 M(-109.7%) | -$11.85 B(+58.9%) |
| Sept 2012 | - | -$518.04 M(-18.4%) | -$7.46 B(+6.2%) |
| June 2012 | - | -$634.96 M(-94.1%) | -$7.02 B(+2.4%) |
| Mar 2012 | - | -$10.74 B(-341.9%) | -$6.85 B(-290.9%) |
| Dec 2011 | $3.59 B(-285.3%) | $4.44 B(-5628.3%) | $3.59 B(-385.3%) |
| Sept 2011 | - | -$80.32 M(-82.9%) | -$1.26 B(-51.1%) |
| June 2011 | - | -$469.79 M(+56.4%) | -$2.57 B(+120.0%) |
| Mar 2011 | - | -$300.38 M(-26.3%) | -$1.17 B(-39.7%) |
| Dec 2010 | -$1.94 B(-12.6%) | -$407.82 M(-70.7%) | -$1.94 B(+0.5%) |
| Sept 2010 | - | -$1.39 B(-249.4%) | -$1.93 B(+100.8%) |
| June 2010 | - | $932.97 M(-187.3%) | -$960.14 M(-67.5%) |
| Mar 2010 | - | -$1.07 B(+168.8%) | -$2.96 B(+33.4%) |
| Dec 2009 | -$2.22 B(+1139.2%) | -$397.68 M(-6.8%) | -$2.22 B(+40.3%) |
| Sept 2009 | - | -$426.65 M(-59.9%) | -$1.58 B(+7.3%) |
| June 2009 | - | -$1.06 B(+223.8%) | -$1.47 B(+283.4%) |
| Mar 2009 | - | -$328.39 M(-237.6%) | -$383.99 M(+114.7%) |
| Dec 2008 | -$178.82 M | $238.57 M(-174.8%) | -$178.82 M(-67.3%) |
| Sept 2008 | - | -$319.08 M(-1381.4%) | -$547.37 M(-13.0%) |
| June 2008 | - | $24.90 M(-120.2%) | -$629.03 M(-24.7%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2008 | - | -$123.22 M(-5.2%) | -$835.25 M(-35.9%) |
| Dec 2007 | -$1.30 B(-25.1%) | -$129.98 M(-67.6%) | -$1.30 B(-7.6%) |
| Sept 2007 | - | -$400.74 M(+121.0%) | -$1.41 B(-11.7%) |
| June 2007 | - | -$181.32 M(-69.3%) | -$1.60 B(-2.6%) |
| Mar 2007 | - | -$590.43 M(+148.6%) | -$1.64 B(-5.7%) |
| Dec 2006 | -$1.74 B(+154.9%) | -$237.47 M(-59.6%) | -$1.74 B(-15.3%) |
| Sept 2006 | - | -$587.14 M(+161.3%) | -$2.05 B(+32.2%) |
| June 2006 | - | -$224.73 M(-67.4%) | -$1.55 B(+35.7%) |
| Mar 2006 | - | -$689.99 M(+25.0%) | -$1.14 B(+67.8%) |
| Dec 2005 | -$682.48 M(+40.0%) | -$551.80 M(+533.6%) | -$682.48 M(+148.3%) |
| Sept 2005 | - | -$87.09 M(-147.4%) | -$274.90 M(-7.8%) |
| June 2005 | - | $183.91 M(-180.8%) | -$298.10 M(-47.0%) |
| Mar 2005 | - | -$227.51 M(+57.8%) | -$562.41 M(+15.4%) |
| Dec 2004 | -$487.41 M(-33.0%) | -$144.22 M(+30.8%) | -$487.41 M(+35.9%) |
| Sept 2004 | - | -$110.29 M(+37.2%) | -$358.60 M(-7.7%) |
| June 2004 | - | -$80.40 M(-47.3%) | -$388.70 M(+17.3%) |
| Mar 2004 | - | -$152.51 M(+890.1%) | -$331.50 M(-54.4%) |
| Dec 2003 | -$727.35 M(-1687.3%) | -$15.40 M(-89.0%) | -$727.35 M(+22.9%) |
| Sept 2003 | - | -$140.39 M(+505.2%) | -$591.75 M(+23.5%) |
| June 2003 | - | -$23.20 M(-95.8%) | -$478.97 M(+4.2%) |
| Mar 2003 | - | -$548.35 M(-556.3%) | -$459.69 M(-1103.2%) |
| Dec 2002 | $45.82 M(+120.5%) | $120.19 M(-535.3%) | $45.82 M(+52.7%) |
| Sept 2002 | - | -$27.61 M(+606.1%) | $30.01 M(-60.2%) |
| June 2002 | - | -$3.91 M(-90.9%) | $75.33 M(+9.3%) |
| Mar 2002 | - | -$42.85 M(-141.0%) | $68.94 M(+231.7%) |
| Dec 2001 | $20.78 M(-124.7%) | $104.38 M(+489.4%) | $20.78 M(-113.6%) |
| Sept 2001 | - | $17.71 M(-271.9%) | -$152.47 M(-11.1%) |
| June 2001 | - | -$10.30 M(-88.7%) | -$171.59 M(+6.2%) |
| Mar 2001 | - | -$91.00 M(+32.1%) | -$161.64 M(+92.0%) |
| Dec 2000 | -$84.20 M(+416.6%) | -$68.87 M(+4767.3%) | -$84.20 M(+148.9%) |
| Sept 2000 | - | -$1.42 M(+300.8%) | -$33.83 M(-47.6%) |
| June 2000 | - | -$353.00 K(-97.4%) | -$64.50 M(+4.5%) |
| Mar 2000 | - | -$13.56 M(-26.7%) | -$61.74 M(+278.8%) |
| Dec 1999 | -$16.30 M(-124.2%) | -$18.50 M(-42.3%) | -$16.30 M(-552.8%) |
| Sept 1999 | - | -$32.09 M(-1432.0%) | $3.60 M(-95.9%) |
| June 1999 | - | $2.41 M(-92.4%) | $88.19 M(-3.2%) |
| Mar 1999 | - | $31.88 M(+2177.1%) | $91.08 M(+35.1%) |
| Dec 1998 | $67.40 M(-147.6%) | $1.40 M(-97.3%) | $67.40 M(+35.1%) |
| Sept 1998 | - | $52.50 M(+890.6%) | $49.90 M(-155.0%) |
| June 1998 | - | $5.30 M(-35.4%) | -$90.80 M(-11.2%) |
| Mar 1998 | - | $8.20 M(-150.9%) | -$102.20 M(-27.8%) |
| Dec 1997 | -$141.50 M(+258.2%) | -$16.10 M(-81.7%) | -$141.50 M(-10.0%) |
| Sept 1997 | - | -$88.20 M(+1345.9%) | -$157.20 M(+64.6%) |
| June 1997 | - | -$6.10 M(-80.4%) | -$95.50 M(-269.6%) |
| Mar 1997 | - | -$31.10 M(-2.2%) | $56.30 M(-242.5%) |
| Dec 1996 | -$39.50 M(-43.5%) | -$31.80 M(+20.0%) | -$39.50 M(+413.0%) |
| Sept 1996 | - | -$26.50 M(-118.2%) | -$7.70 M(+1440.0%) |
| June 1996 | - | $145.70 M(-214.8%) | -$500.00 K(-99.7%) |
| Mar 1996 | - | -$126.90 M(+557.5%) | -$160.40 M(+1070.8%) |
| Dec 1995 | -$69.90 M(-277.4%) | - | - |
| Sept 1995 | - | -$19.30 M(+35.9%) | -$13.70 M(+80.3%) |
| June 1995 | - | -$14.20 M(-161.2%) | -$7.60 M(-119.3%) |
| Mar 1995 | - | $23.20 M(-782.4%) | $39.40 M(+42.8%) |
| Mar 1995 | $39.40 M(+22.7%) | - | - |
| Dec 1994 | - | -$3.40 M(-74.2%) | $27.60 M(-35.8%) |
| Sept 1994 | - | -$13.20 M(-140.2%) | $43.00 M(-25.3%) |
| June 1994 | - | $32.80 M(+187.7%) | $57.60 M(+79.4%) |
| Mar 1994 | $32.10 M(-125.9%) | $11.40 M(-5.0%) | $32.10 M(-221.1%) |
| Dec 1993 | - | $12.00 M(+757.1%) | -$26.50 M(-14.2%) |
| Sept 1993 | - | $1.40 M(-80.8%) | -$30.90 M(-36.9%) |
| June 1993 | - | $7.30 M(-115.5%) | -$49.00 M(-60.5%) |
| Mar 1993 | -$124.10 M(+589.4%) | -$47.20 M(-721.1%) | -$124.10 M(+61.4%) |
| Dec 1992 | - | $7.60 M(-145.5%) | -$76.90 M(-9.0%) |
| Sept 1992 | - | -$16.70 M(-75.4%) | -$84.50 M(+24.6%) |
| June 1992 | - | -$67.80 M | -$67.80 M |
| Mar 1992 | -$18.00 M(+5900.0%) | - | - |
| Mar 1991 | -$300.00 K | - | - |
FAQ
- What is Gilead Sciences annual cash flow from investing activities?
- What is the all time high annual CFI for Gilead Sciences?
- What is Gilead Sciences quarterly cash flow from investing activities?
- What is the all time high quarterly CFI for Gilead Sciences?
- What is Gilead Sciences quarterly CFI year-on-year change?
- What is Gilead Sciences TTM cash flow from investing activities?
- What is the all time high TTM CFI for Gilead Sciences?
- What is Gilead Sciences TTM CFI year-on-year change?
What is Gilead Sciences annual cash flow from investing activities?
The current annual CFI of GILD is -$2.27 B
What is the all time high annual CFI for Gilead Sciences?
Gilead Sciences all-time high annual cash flow from investing activities is $14.36 B
What is Gilead Sciences quarterly cash flow from investing activities?
The current quarterly CFI of GILD is -$710.00 M
What is the all time high quarterly CFI for Gilead Sciences?
Gilead Sciences all-time high quarterly cash flow from investing activities is $5.24 B
What is Gilead Sciences quarterly CFI year-on-year change?
Over the past year, GILD quarterly cash flow from investing activities has changed by +$17.00 M (+2.34%)
What is Gilead Sciences TTM cash flow from investing activities?
The current TTM CFI of GILD is -$3.95 B
What is the all time high TTM CFI for Gilead Sciences?
Gilead Sciences all-time high TTM cash flow from investing activities is $14.36 B
What is Gilead Sciences TTM CFI year-on-year change?
Over the past year, GILD TTM cash flow from investing activities has changed by -$1.69 B (-74.44%)